Leukotriene B4 as a Potential Therapeutic Target for the Treatment of Metabolic Disorders.
Institute of Biomedical Science, University of São Paulo , São Paulo , Brazil.
Luciano Ribeiro
LR
Filgueiras
Department of Microbiology and Immunology, Indiana University School of Medicine , Indianapolis, IN , USA.
C Henrique
CH
Serezani
Department of Microbiology and Immunology, Indiana University School of Medicine , Indianapolis, IN , USA.
Sonia
S
Jancar
Diabetes; Leukotriene B4; insulin resistance; metabolic disorders; sterile inflammation